Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Madrigal Pharmaceuticals Inc
F:YDO1
Madrigal Pharmaceuticals Inc
F:YDO1
Price:
356.5
EUR
0.88%
Market Cap:
€7.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Madrigal Pharmaceuticals Inc
F:YDO1
|
US |
|
R
|
Randstad NV
XMUN:RSH
|
NL |
Wall St Price Targets
YDO1 Price Forecast
Based on 20 analysts
Based on 20 analysts
+61% Upside
from
€356.5
today
Madrigal Pharmaceuticals Inc (YDO1)’s 12-month stock price forecast through November 2027 has a consensus target of €575.48, implying 61% upside. The forecast is based on price targets from 20 Wall Street analysts.
YDO1 Analyst Rating
No ratings yet
No ratings yet
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YDO1's stock price target?
Price Target
575.48
EUR
575.48
EUR
According to Wall Street analysts, the average 1-year price target for YDO1 is 575.48 EUR with a low forecast of 453.32 EUR and a high forecast of 850.59 EUR.
What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
27%
27%
Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 27%.
What is the Gross Profit forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%
26%
The compound annual growth rate for Gross Profit over the next 8 years is 26%.
